Table 4.
Dose (mg/kg) | Male | Female | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
0 | 2000 | 1000 | 500 | 250 | 125 | 0 | 2000 | 1000 | 500 | 250 | 125 | |
Lung | ||||||||||||
Normal | 4/5 | 4/5 | 4/5 | 4/5 | 4/5 | 4/5 | 3/5 | 5/5 | 4/5 | 4/5 | 4/5 | 4/5 |
Congestion | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 0/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Thymus | ||||||||||||
Normal | 4/5 | 5/5 | 4/5 | 3/5 | 3/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 | 4/5 |
Atrophy | 1/5 | 0/5 | 1/5 | 2/5 | 2/5 | 1/5 | 1/5 | 0/5 | 2/5 | 2/5 | 2/5 | 1/5 |
Kidney | ||||||||||||
Normal | 5/5 | 5/5 | 5/5 | 5/5 | 4/5 | 5/5 | 5/5 | 5/5 | 5/5 | 5/5 | 4/5 | 5/5 |
Cyst | 0/5 | 0/5 | 0/5 | 0/5 | 1/5 | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 | 1/5 | 0/5 |
Spleen | ||||||||||||
Normal | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 4/5 | 3/5 | 4/5 | 3/5 | 5/5 |
Atrophy | 2/5 | 1/5 | 2/5 | 1/5 | 2/5 | 0/5 | 2/5 | 1/5 | 2/5 | 1/5 | 2/5 | 0/5 |
Hypertrophy | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 | 1/5 | 1/5 | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 |
LNa | ||||||||||||
Normal | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 | 5/5 | 2/5 | 1/5 | 5/5 | 3/5 | 3/5 | 5/5 |
Hypertrophy | 2/5 | 1/5 | 3/5 | 1/5 | 1/5 | 0/5 | 3/5 | 4/5 | 0/5 | 2/5 | 2/5 | 0/5 |
Focal hemorrhage | 0/5 | 0/5 | 1/5 | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 |
Observed animals/total observed animals (five mice).
aBilateral popliteal lymph node.